Quantification of Group B Streptococcus Load in the Mouse Vaginal Lumen via Swabbing and Chromogenic Culture
JoVE Encyclopedia of Experiments
Microbiology
0 views • 2:34 min • February 26th, 2026
Loading...
Overview
This study outlines a method for quantifying group B Streptococcus (GBS) in a mouse model. The technique involves vaginal swabbing and bacterial culture on differential agar to visualize GBS colonies.
Key Study Components
Area of Science
- Microbiology
- Infectious Diseases
- Animal Models
Background
- Group B Streptococcus is an opportunistic pathogen.
- Understanding its persistence in hosts is crucial for infection control.
- Quantitative methods are needed to assess bacterial load.
- Vaginal colonization models are commonly used in research.
Purpose of Study
- To develop a reliable method for quantifying GBS in a mouse model.
- To assess the effectiveness of the swabbing technique.
- To visualize GBS colonies for accurate counting.
Methods Used
- Female mice were colonized with GBS.
- Vaginal swabs were taken using a buffer-moistened swab.
- The swab was placed in a buffer and agitated to release bacteria.
- Serial dilutions were plated on chromogenic differential agar for incubation.
Main Results
- GBS colonies appeared as pink or mauve on the agar plates.
- The method allowed for quantification of GBS load.
- Incubation conditions were optimized for bacterial growth.
- The technique demonstrated reproducibility in results.
Conclusions
- The developed method is effective for quantifying GBS in vivo.
- This approach can be used for further studies on GBS persistence.
- Future research may explore the implications of GBS colonization.
Frequently Asked Questions
What is group B Streptococcus?
Group B Streptococcus (GBS) is a type of bacteria that can cause infections in newborns and pregnant women.
Why is quantifying GBS important?
Quantifying GBS helps in understanding its role in infections and developing treatment strategies.
What method is used to visualize GBS colonies?
GBS colonies are visualized using chromogenic differential agar, which produces distinct color changes.
How are the swabs prepared for sampling?
Swabs are moistened with buffer and inserted into the vaginal lumen to collect bacteria.
What are the incubation conditions for the agar plates?
The agar plates are incubated at 37 degrees Celsius for 24 hours.
Can this method be used for other bacteria?
While this method is tailored for GBS, similar techniques can be adapted for other bacterial pathogens.
Executive Industry Relevance
Quantifying pathogen load in vivo is critical for evaluating antimicrobial efficacy and host-pathogen interactions in preclinical infectious disease models. This swab-and-culture method provides a reproducible, quantitative readout for Group B Streptococcus vaginal colonization, supporting target validation and mechanistic de-risking in anti-infective discovery programs. The chromogenic assay enables clear visual discrimination of target colonies, facilitating high-confidence data generation for go/no-go decisions in early therapeutic development.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by measuring bacterial burden as a functional readout of target engagement.
- Operational Value: Provides a standardized, quantifiable metric for assessing colonization persistence across experimental groups.
- Predictive Value: Supports dose-response modeling and target de-risking through longitudinal load tracking.
Screening & Assay Development
- Assay Readiness: Chromogenic plating yields visually distinct colonies, reducing ambiguity in manual counting and improving inter-operator reproducibility.
- Quantitative Output: Serial dilution and CFU enumeration generate actionable load data for compound screening and lead optimization.
- Scalability: Buffer-based swab elution and dilution series support medium-throughput evaluation of antimicrobial candidates.
Translational & Preclinical Research
- Disease Relevance: Models human vaginal GBS colonization, enabling preclinical evaluation of interventions aimed at reducing perinatal transmission risk.
- Translational Continuity: Load quantification bridges discovery and preclinical stages by providing a consistent biomarker of colonization dynamics.
- Mechanistic De-risking: Allows assessment of virulence factor inhibition or immune modulation effects on bacterial persistence.
Pipeline & Workflow Integration
This method fits within the infectious disease discovery continuum from target validation through lead identification to preclinical efficacy testing, where bacterial load serves as a key pharmacodynamic biomarker.
- Discovery Biology: Supports hypothesis testing by linking genetic or pharmacological interventions to measurable changes in GBS burden.
- Screening: Enables reproducible compound evaluation via standardized swabbing, dilution, and chromogenic plating workflows.
- Analytics: Colony counting provides quantitative CFU/mL readouts that support statistical comparison across treatment conditions.
- Translational Research: Load data inform advancement decisions by correlating with reduced transmission risk in preclinical models.
- Enterprise Reuse: The swab-and-culture platform is adaptable to other vaginal or mucosal pathogens with appropriate selective media.
Operational & Enterprise Impact
- Scientific Value: Delivers target-specific, quantifiable data that reduces ambiguity in antimicrobial mechanism of action.
- Operational Value: Buffer elution and vortex disruption ensure consistent bacterial recovery, enhancing assay robustness.
- Strategic Value: Enables evidence-based prioritization of candidates based on colonization reduction efficacy.
- Portfolio Impact: Supports risk-adjusted advancement by quantifying biological activity in a disease-relevant system.
Implementation Considerations
- Requires aseptic technique and training in murine vaginal handling to ensure sample integrity.
- Dependent on access to chromogenic differential agar and anaerobic or CO2 incubation capacity for optimal GBS growth.
- Necessitates standardized swab insertion depth and rotation protocol to minimize inter-animal variability.
- Requires biosafety level 2 compliance for handling GBS and processing contaminated swabs.
- Limited to cultivable organisms; not applicable to non-culturable or fastidious pathogens without media adaptation.
Biopharma FAQs
Why does colony counting matter for target validation in GBS studies?
Colony counting provides a quantitative measure of bacterial load, enabling assessment of therapeutic impact on colonization persistence. This metric supports target validation by linking interventions to measurable reductions in GBS burden in vivo.
How does serial dilution enable accurate quantification in the swabbing workflow?
Serial dilution of the eluted swab sample allows plating of equivalent bacterial volumes across concentrations, ensuring countable colonies for CFU calculation. This step is essential for generating reproducible, quantitative load data from vaginal samples.
What does chromogenic substrate hydrolysis enable in GBS detection?
Chromogenic substrate hydrolysis by GBS-specific enzymes leads to colored colony formation, visually distinguishing target bacteria from background flora. This visual specificity improves counting accuracy and reduces false positives in mixed microbial samples.
Why are replication requirements important for cross-functional collaboration in infection models?
Replicate swabbing and plating ensure data reliability, which is critical for aligning biology, pharmacology, and toxicology teams on efficacy trends. Consistent replication supports confident interpretation of load reduction across study arms.
What statistical analysis is needed before implementing this assay in lead identification?
Implementation requires baseline variability assessment and power analysis to determine group sizes capable of detecting biologically relevant load differences. Appropriate parametric or non-parametric tests must be selected based on data distribution and variance equality.
07:34
Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis
Related Videos
0 Views
08:46
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Related Videos
0 Views
08:53
Models of Murine Vaginal Colonization by Anaerobically Grown Bacteria
Related Videos
0 Views
12:50
Measuring Bacterial Load and Immune Responses in Mice Infected with Listeria monocytogenes
Related Videos
0 Views
11:09
Multiplex Detection of Bacteria in Complex Clinical and Environmental Samples using Oligonucleotide-coupled Fluorescent Microspheres
Related Videos
0 Views
02:58
Modeling Murine Vaginal Colonization by Anaerobic Bacteria
Related Videos
0 Views
02:42
Quantification of Tissue Bacterial Load in a Mouse Model of Chronic Intestinal Infection
Related Videos
0 Views
02:51
Preparation of Gardnerella vaginalis Inoculum to Model Recurrent Urinary Tract Infections in Mice
Related Videos
0 Views
03:42
Establishing a Mouse Model of Vaginal Group B Streptococcus Infection
Related Videos
0 Views
04:21
Quantifying Bacterial Load in the Mouse Heart Following Tail Vein Injection of Listeria monocytogenes
Related Videos
0 Views
Last updated: 1 August 2026